
Pharmax Corporation Ltd
About Pharmax Corporation Ltd
Data last updated:
Pharmax Corporation Ltd is a public limited company based in New Delhi, Delhi, India, a subsidiary of Max Estates Limited. It operates in the real estate financing segment of the financial services sector. It was incorporated on 27 September 1989 and has been in existence for over 37 years.
The company is registered with the Registrar of Companies (ROC), Delhi, under CIN U24232DL1989PLC458933. Its GSTIN is 07AABCP2746C1ZR (Delhi).
The company has an authorised share capital of ₹28.7 Cr and a paid-up capital of ₹8.46 Cr. It is led by directors including Benjamin Scott Greene and Jillian Leigh Moo Young.
Its last annual general meeting (AGM) was held on 25 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at Max House 1 Dr. Jha Marg Okhla New Delhi – 110020, Delhi, India – 110020.
As per the financials filed for FY 2025, the company reported a revenue of ₹41.1 Cr, reflecting significant growth compared to the previous year. For the same year it recorded a net profit of ₹8.59 Cr (net margin 20.9%) and EBITDA of ₹35.6 Cr (EBITDA margin 86.6%). Revenue has grown at a compounded annual rate (CAGR) of 121% over three years and 172% over five years.
The company has about 12 employees on its provident fund (EPFO) records.
As per MCA filings, the company has open charges of ₹249.02 Cr and satisfied charges of ₹293 Cr on record. Court records list 8 cases involving the company, including 5 filed by the company and 3 filed against it; 1 case is pending. The company has 1 deal on record (1 acquisition); the latest was in June 2019.
The current compliance status is marked as compliant by the Registrar of Companies.
Company details
CIN history
Pharmax Corporation has 2 previous CINs, indicating changes in the company's corporate structure or registration details. The current CIN is U24232DL1989PLC458933, which is the unique identifier assigned by the Registrar of Companies.
| CIN | Status |
|---|---|
| U24232DL1989PLC458933 | Current |
| U24232PB1989PLC009741 | Previous |
| L24232PB1989PLC009741 | Previous |
Contact details
Pharmax Corporation Ltd's registered office is in New Delhi, Delhi.
- Registered AddressMax House 1 Dr. Jha Marg Okhla New Delhi – 110020, Delhi, India – 110020
- IndustryFinancial Services, Real Estate Financing
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Business activity
The main business activity of Pharmax Corporation is real estate. In detail, this covers real estate activities with own or leased property.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| L | Real Estate | L1 | Real estate activities with own or leased property |
To see the full business activity and turnover split of Pharmax Corporation Ltd, buy the company report.
Financials of Pharmax Corporation Ltd
FY 2025 filings availablePharmax Corporation Ltd reported revenue of ₹41.1 Cr (up 264% YoY) for FY 2025.
Compounded Annual Growth Rate (CAGR)
Revenue has grown at a compounded annual rate (CAGR) of 172% over five years, including 264% growth in the latest year. EBITDA rose 280% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | ₹35.6 Cr | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | ₹8.59 Cr | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 86.6% | ||||
| Net Profit Margin | 20.9% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Pharmax Corporation Ltd, buy the company report.
Board of directors of Pharmax Corporation Ltd
Pharmax Corporation has 6 current directors and 18 former directors. Current directors are listed first, with their designation and appointment date.
Charges & borrowings
| Date | Charge ID | Lender | Amount | Status | Modified or satisfied on |
|---|---|---|---|---|---|
| 20 Dec 2024 | 101019701 | Others | ₹97.02 Cr | Open | |
| 28 Jun 2024 | 100943823 | Others | ₹152 Cr | Open | |
| 23 Feb 2024 | 100873703 | Others | ₹50 Cr | Satisfied | |
| 19 Oct 2022 | 100622182 | Others | ₹68 Cr | Satisfied | |
| 10 Nov 2021 | 100499044 | Others | ₹65 Cr | Satisfied |
To see the full charge records of Pharmax Corporation Ltd, buy the company report.
Total charge records: 8 View all charges
Deals & funding
Pharmax Corporation Ltd has 1 deal on record (1 acquisition); the latest was in June 2019.
Deals on record (1 of 1)
| When | Deal | Amount | Parties |
|---|---|---|---|
| Jun 2019 | Acquisition | ₹60.52 Cr | Buyer: Max Estates Limited Seller: Max India |
Deal records are compiled from filings and public sources; amounts are shown only where the source reported them.
Legal cases
Pharmax Corporation Ltd has 8 court cases on record: 5 filed by Pharmax Corporation, 3 filed against it. 1 case is pending and 7 are disposed.
Cases by court
| Court | Cases | Against the company | Pending |
|---|---|---|---|
| High courts | 4 | 2 | 1 |
| District courts | 3 | 1 | 0 |
| NCLT | 1 | 0 | 0 |
Cases on record (5 of 8)
| Court | Type of case | Party | Status |
|---|---|---|---|
| High Court of Delhi | Appeal | Filed against the company by M/S Freeway Marketing India Pvt Ltd | Disposed |
| District court, New Delhi, Delhi | Criminal case | Filed by the company against Ms Freeway Marketing India Pvt. Ltd. and 1 other | Disposed |
| District court, South East, Delhi | Criminal case | Filed by the company against Ms Freeway Marketing India Pvt. Ltd. and 1 other | Disposed |
| High Court, GUJARAT | Special civil application | Filed against the company by an individual | Pending |
| High Court of Delhi | Writ petition | Filed by the company against Union of India & Ors. | Disposed |
To see the full case history of Pharmax Corporation Ltd, buy the company report.
Case records are compiled from court listings and may lag the court's own records. A case filed against a company is not a finding against it.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Pharmax Corporation Ltd; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
Pharmax Corporation has 1 GST registration: 1 active.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 07AABCP2746C1ZR | Delhi | Active | 01 Jul 2017 |
To see the full GST registrations and return filing status of Pharmax Corporation Ltd, buy the company report.
Recent activity
Pharmax Corporation Ltd has 24 board changes on record since 1997: 6 appointments and 18 cessations. The latest: Archit Goyal was appointed as Additional Director on 01 Oct 2025.
33 earlier events are in the company report.
Frequently asked questions
Pharmax Corporation is an active public limited company based in New Delhi, Delhi, India. The company works in real estate financing, within the financial services industry. It was incorporated on 27 September 1989 (37+ years old) and is registered under CIN U24232DL1989PLC458933.
Pharmax Corporation has 6 current directors:
- Benjamin Scott Greene - Director
- Archit Goyal - Additional Director
- Jillian Leigh Moo Young - Director
- Monika Srivastava - Director
- Kishansingh Ramsinghaney - Director
- Akhil Bhalla - Director
The latest financial statements of Pharmax Corporation on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 25 September 2025. Year-wise statements from 2015 are in the company report.
The GSTIN of Pharmax Corporation is 07AABCP2746C1ZR, registered in Delhi.
The CIN (Corporate Identification Number) of Pharmax Corporation is U24232DL1989PLC458933. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Pharmax Corporation has 8 court cases on record: 5 filed by the company and 3 filed against it. 1 is pending. Most are in the high courts.
Pharmax Corporation was incorporated on 27 September 1989, making it 37+ years old. It is registered with the Registrar of Companies, Delhi.
Pharmax Corporation has 1 deal on record (1 acquisition); the latest was in June 2019.
Archit Goyal was appointed as Additional Director on 01 Oct 2025. Akhil Bhalla was appointed as Director on 24 Sep 2024. Akhil Bhalla ceased to be Additional Director on 24 Sep 2024. Pharmax Corporation has 24 board changes on record in total.
The registered office of Pharmax Corporation is at Max House 1 Dr. Jha Marg Okhla New Delhi – 110020, Delhi, India – 110020.